Medtronic
MDT
2,125 hedge funds and large institutions have $86.7B invested in Medtronic in 2026 Q2 according to their latest regulatory filings, with 167 funds opening new positions, 848 increasing their positions, 914 reducing their positions, and 244 closing their positions.
10% more call options, than puts
Call options by funds: $854M | Put options by funds: $773M
0.14% less ownership
Funds ownership: 85.33% → 85.19% (-0.14%)
7% less repeat investments, than reductions
Existing positions increased: 848 | Existing positions reduced: 914
5% less funds holding
Funds holding: 2,244 → 2,125 (-119)
9% less capital invested
Capital invested by funds: $95.7B → $86.7B (-$9.07B)
15% less funds holding in top 10
Funds holding in top 10: 27 → 23 (-4)
32% less first-time investments, than exits
New positions opened: 167 | Existing positions closed: 244
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$664M |
| 2 |
SG Americas Securities
New York
|
+$524M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$354M |
| 4 |
First Eagle Investment Management
New York
|
+$302M |
| 5 |
D.E. Shaw & Co
New York
|
+$283M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$2.31B |
| 2 |
JP Morgan Chase
New York
|
-$1.87B |
| 3 |
UBS AM
Chicago,
Illinois
|
-$735M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$656M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$379M |
MDT Hedge Fund Activity: Q2 2026 in Review
2,125 of the 8,273 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2026, worth a combined $86.7B — down 9.5% from $95.7B a quarter earlier.
Sellers outnumbered buyers: 244 funds closed out of MDT and 167 opened new positions — a net loss of 77 holders — while 914 trimmed existing stakes and 848 added.
The largest buyer was Arrowstreet Capital, adding an estimated $664M. The largest seller was Capital Research Global Investors, cutting an estimated $2.31B.
- 2,125 institutional investors held Medtronic (MDT) as of Q2 2026, down from 2,244 in Q1 2026.
- Funds reported $86.7B of Medtronic stock for Q2 2026, down 9.5% quarter-over-quarter.
- 167 funds opened new Medtronic positions in Q2 2026 and 244 closed out, a net change of -77 holders.
- The largest Medtronic buyer in Q2 2026 was Arrowstreet Capital, an estimated $664M added.
- The largest Medtronic seller in Q2 2026 was Capital Research Global Investors, an estimated $2.31B sold.
Based on aggregated 13F filings for Q2 2026.